Skip to main content
. 2021 Mar 4;13(3):e13698. doi: 10.7759/cureus.13698

Table 6. Use of miltefosine for Balamuthia GAE.

AmB: amphotericin B, Rif: rifampin, Flu: fluconazole, AZM: azithromycin, Dex: dexamethasone, Acy: acyclovir, Van: vancomycin, CFX: ceftriaxone, Deoxy AmB IV: deoxycholate amphotericin B intravenously, TMP-SMX: trimethoprim-sulfamethoxazole, 5-FC: flucytosine, GAE: granulomatous amebic encephalitis

Reference Case (age, sex) Diagnosis from symptom to onset Initial treatment Miltefosine initiation from diagnosis Total days of treatment Outcome Follow-up
[33] 21, female Four months Fluconazole, clotrimazole, topical steroid, fluconazole and clarithromycin, TMP-SMX, albendazole > two years one year Survived 30 months of treatment including 12 months without therapy or recurrence
[34] 26, male Two months Dex, albendazole, Azm, Flu,TMP-SMX Third week 114 days Survived Continued nine months of treatment minus miltefosine
[35] 69, female Three days Azm, Flu, 5-FC, Sulfadiazine, pentamidine On 3rd day Three days Died A few weeks after transfer to hospice care
[36] 11, male Weeks Dex, AmB, Flu, Azithromycin, 5-FC, Sulfadiazine, pentamidine, metronidazole On 7th day 27 days Died Palliative care on day 49